Review: the role of GSDMD in sepsis

Ruifei Shao1,2, Xiran Lou2, Jinfang Xue2

  • 1Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, People's Republic of China.

Abstract

Insights

Gasdermin D (GSDMD) executes pyroptosis, a cell death process crucial in sepsis. Inhibiting GSDMD may offer targeted sepsis treatment by reducing pyroptosis and inflammation.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathology

Background:

  • Sepsis involves dysregulated host responses, leading to hyperinflammation and organ dysfunction.
  • Gasdermin D (GSDMD) is the key executor of pyroptosis, a pro-inflammatory cell death pathway.
  • Pyroptosis is critical for innate immunity and bacterial clearance, but its dysregulation contributes to sepsis severity.

Conclusions:

  • Pyroptosis is central to the inflammatory process in sepsis.
  • Targeting GSDMD with inhibitors presents a potential therapeutic strategy for sepsis.
  • GSDMD is a key mediator linking infection to inflammatory outcomes in sepsis.